Point of care tests require more than rapid reaction times; they depend on consistent reagent preparation, controlled materials, reliable signal development, clear instructions, and stable packaging. Jiuhe develops and supplies IVD products across immunoassay, colloidal gold, and fluorescence immunoassay technologies, supporting applications from routine screening to specialized clinical assessment. Its portfolio includes diagnostic kits and analyzer-based solutions designed for decentralized testing environments. Selected assays can provide results in approximately 10–15 minutes, helping healthcare providers shorten the interval between sample collection and preliminary evaluation. Applicable products can support 2–30°C storage, which can simplify logistics for distributors serving regions with limited cold-chain infrastructure. In practical applications, HbA1c can support diabetes monitoring, while D-Dimer, PCT/CRP, IL-6, and other assays address different cardiovascular and inflammatory testing needs. For international buyers, this broad portfolio enables application-specific product combinations, helping clinics, laboratories, and distributors build scalable point of care tests programs around actual market demand.